Orexigen, Valeant Pharmaceuticals deal

Orexigen’s Orexigen Therapeutics Ireland Ltd. subsidiary granted Valeant’s Valeant Canada L.P. subsidiary exclusive rights to develop and commercialize obesity drug Contrave naltrexone/bupropion in C...